Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients

Protecting vulnerable groups from severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection is mandatory. Immune responses after a third vaccination against SARS-CoV-2 are insufficiently studied in patients after hematopoietic stem-cell transplantation (HSCT). We analyzed immune re...

Descripción completa

Detalles Bibliográficos
Autores principales: Thümmler, Laura, Koldehoff, Michael, Fisenkci, Neslinur, Brochhagen, Leonie, Horn, Peter A., Krawczyk, Adalbert, Lindemann, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230894/
https://www.ncbi.nlm.nih.gov/pubmed/35746580
http://dx.doi.org/10.3390/vaccines10060972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230894/
https://www.ncbi.nlm.nih.gov/pubmed/35746580
http://dx.doi.org/10.3390/vaccines10060972

Ejemplares similares